Select login type
xCHOOSE A PAGE TO ACCESS
x- WGXI Patient Involvement: Workplans, drafts, TC notes ...
- WGXI Patient Involvement: Background Documents
- WGXI Patient Involvement: Face-to-face meetings
- WGXII Benefit-risk Working Group Documents
- WGXVI Development Safety Update Report Working Group Documents
- WGXII Benefit-risk Working Group Documents
- WGXIII Real-world Data Working Group Documents
- SCAR Working Group Documents
- Educational Standards Working Group Documents
- Good Governance Practice for Research Institutions Working Group Documents
- Pharmacoepidemiology for Public Health Working Group Documents
- MedDRA Labelling Groupings Working Group Documents
- Clinical Research in Resource-limited Settings Working Group Documents
- Login
Effectiveness of mobile applications in enhancing adverse drug reaction reporting
- Home
- Effectiveness of mobile applications in enhancing adverse drug reaction reporting
Adverse drug reactions (ADRs) have a significant impact on the healthcare system worldwide. Underreporting of ADRs is identified as a main issue in pharmacovigilance. Mobile applications(apps) have been introduced as a solution for the underreporting of ADRs. This systematic review was conducted to assess the efficacy of the mobile applications in enhancing ADR reporting.